BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 6890361)

  • 1. [Dose-response relationship and duration of action of acebutolol / investigations on heart rate behaviour and ischemic ST-segment depression].
    Kober G; Mikludy R; Veidt J; Kaltenbach M
    Arzneimittelforschung; 1982; 32(8):835-9. PubMed ID: 6890361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Heart rate behavior and the ischemic ST-segment under carteolol hydrochloride. Dose-response relationship and duration of effect].
    Kober G; Veidt J; Mikludy R; Kaltenbach M
    Arzneimittelforschung; 1983; 33(2a):313-7. PubMed ID: 6682323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cardiac ischemia on exercise. Effect of nifedipine and acebutolol singly and in combination (author's transl)].
    Strasser R; Klepzig H
    MMW Munch Med Wochenschr; 1981 Aug; 123(35):1303-6. PubMed ID: 6793850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acebutolol, a new beta-receptor antagonist on heart rate and rate-pressure product in normal subjects.
    Sharma PL
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):290-7. PubMed ID: 1002366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of bisoprolol and acebutolol on resting blood pressure and on exercise blood pressure profile in hypertensive patients: a comparative, single-blind study.
    Bouvier JM; Rabot D; Herrero G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S179-83. PubMed ID: 11527124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic effects of acebutolol and propranolol in hypertensive patients during exercise.
    Reim HG; Wagner W
    Int J Clin Pharmacol Ther Toxicol; 1985 May; 23(5):238-43. PubMed ID: 4008112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of acebutolol on dynamic ischemic ECG changes: a study using ambulatory twenty-four-hour ECG monitoring.
    Admon D; Kamchi A; Lewis BS; Gotsman MS
    Isr J Med Sci; 1979 Mar; 15(3):207-11. PubMed ID: 37190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Dose-response relationship of nisoldipine in patients with stable angina pectoris and stress-induced myocardial ischemia].
    Grönefeld G; Bernhardt J; Schneider W
    Z Kardiol; 1993 Sep; 82(9):573-8. PubMed ID: 8237098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of the alpha 1-receptor blocker prazosin and the beta 1-receptor blocker acebutolol and their combination on blood pressure and pressure rate product. Ergometric studies of hypertensive patients].
    Franz IW
    Z Kardiol; 1984 Jan; 73(1):21-8. PubMed ID: 6367245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Acebutolol in coronary heart disease: an ergometric double-blind study (author's transl)].
    Böhm H; Ludwig B
    Dtsch Med Wochenschr; 1980 Jul; 105(27):958-60. PubMed ID: 7408684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The effect of diltiazem and nifedipine on exercise-induced ST-segment depression and heart rate in patients with coronary heart disease (author's transl)].
    Kober G; Berlad T; Hopf R; Kaltenbach M
    Z Kardiol; 1981 Jan; 70(1):59-65. PubMed ID: 7210779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The beta-blocking effect of diacetolol in humans and its relationship to plasma levels.
    Flouvat B; Roux A; Delhotal B; Lemaigre D; Leroy M; Liot F
    Int J Clin Pharmacol Ther Toxicol; 1982 Aug; 20(8):358-61. PubMed ID: 6126441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative beta-blocking potencies of acebutolol and propranolol relative to plasma drug levels.
    Collett JT; Hendrickson JA; Chew CY; Shah PM; Laddu AR; Singh BN
    Int J Clin Pharmacol Ther Toxicol; 1981 Nov; 19(11):473-8. PubMed ID: 6117519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Acute effects of oral acebutolol on exercise tolerance in patients with stable angina pectoris (author's transl)].
    Scrutinio D; De Toma L; Mangini S; Boscia F; Quagliara D; De Nicolò M; Rizzon P
    G Ital Cardiol; 1981; 11(3):364-72. PubMed ID: 7026336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise testing in the evaluation of coronary artery disease.
    Ellestad MH; Famularo MA; Paliwal YK
    Herz; 1982 Apr; 7(2):76-90. PubMed ID: 6979501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The exercise test with atropine].
    Variola A; Albiero R; Dander B; Buonanno C
    G Ital Cardiol; 1997 Mar; 27(3):255-62. PubMed ID: 9244727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behaviour of the ST segment under stress by atrial frequency and digitalis in latent coronary insufficiency (author's transl)].
    Lehmann HU; Hochrein H; Witt E
    MMW Munch Med Wochenschr; 1977 Jan; 119(1):11-4. PubMed ID: 401933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The effect of beta-receptor antagonists and diuretics and their combination on blood pressure and pressure-rate product during ergometric work in hypertensive patients (author's transl)].
    Franz IW
    Z Kardiol; 1982 Jan; 71(2):129-37. PubMed ID: 7072313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.